Pentacyclic triterpenoids decreased plasma glucose, HbA1c, enhanced plasma insulin, muscle and liver glycogen, and showed protective effects on the liver, eye and heart of diabetic rats, suggesting that they had the potential to prevent diabetes and associated complications [53]. The gene discussed is INS; the disease is diabetes mellitus.